References
- Al-Quteimat, O. M., & Amer, A. M. (2016). Evidence-based pharmaceutical care: The next chapter in pharmacy practice. Saudi Pharmaceutical Journal, 24, 447–451. https://doi.org/10.1016/j.jsps.2014.07.010
- Alsfouk, B. A., Brodie, M. J., Walters, M., Kwan, P., & Chen, Z. (2020). Tolerability of Antiseizure medications in individuals with newly diagnosed epilepsy. JAMA Neurology, 77(5), 574–581. https://doi.org/10.1001/jamaneurol.2020.0032
- Ayalew, M. B., & Muche, E. A. (2018). Patient reported adverse events among epileptic patients taking antiepileptic drugs. SAGE Open Medicine, 6, 1–8. https://doi.org/10.1177/2050312118772471
- Diaz, R. A., Sancho, J., & Serratosa, I. (2008). Antiepileptic drug interactions. Neurologist, 14(Suppl.1), S55–S65. https://doi.org/10.1097/01.nrl.0000340792.61037.40
- Ejeliogu, Uhunmwangho-Courage. (2017). Pattern of adverse drug reaction to antiepileptic drugs at a tertiary hospital in North-Central Nigeria: A prospective observational study. JAMPS, 14(3), 1–9. https://doi.org/10.9734/JAMPS/2017/35337
- French, J. A., & Pedley, T. A. (2008). Clinical Practice. Initial management of epilepsy. The New England Journal of Medicine, 359(2), 166–176. https://doi.org/10.1056/NEJMcp0801738
- Gurshaw, M., Agalu, A., & Chanie, T. (2014). Antiepileptic drug utilization and treatment outcome among epileptic patients on follow-up in a resource poor setting. Journal of Young Pharmacists, 6(3), 2014. https://doi.org/10.5530/jyp.2014.3.8
- Maqbool, M., Dugassa, D., & Fekadu, G. (2021, April). Adverse drug reactions of antiepileptic drugs in the neurology department of a tertiary care hospital, Srinagar, Jammu & Kashmir,India. Archives of Neuroscience, 8(2), e112364. https://doi.org/10.5812/ans.112364
- May, T. W., & Pfafflin, M. The Efficacy of an educational treatment program for patients with epilepsy (MOSES): Results of a controlled, randomized study. (2002). Epilepsia, 43(5), 539–549. Blackwell Publishing, Inc. https://doi.org/10.1046/j.1528-1157.2002.23801.x
- Meador, K. J. (2006). Cognitive and memory effects of new antiepileptic drugs. Epilepsy Research, 68(1), 63–67. https://doi.org/10.1016/j.eplepsyres.2005.09.023
- Reddy, D. S. Clinical pharmacology of current antiepileptic drugs. (2014). International Journal of Pharmaceutical Sciences and Nanotechnology, 7(1), 2305–2319. January-March 2014. https://doi.org/10.37285/ijpsn.2014.7.1.1
- Scottish Intercollegiate Guidelines Network (SIGN). (2015). Diagnosis and management of epilepsy in adults. SIGN. SIGN publication no. 143.
- Shinu, C., & Dilip, C. (2020). Impact of pharmaceutical care programme on health outcome of geriatric Patients. Clinical Epidemiology and Global Health, 8, 894–898. https://doi.org/10.1016/j.cegh.2020.02.019
- Shobhana, M., Sumana, S., Ramesh, L., & Satish, K. M. (2010). Utilization pattern of antiepileptic drugs and their adverse effects in a teaching hospital. Asian Journal of Pharmaceutical and Clinical Research, 3(1), 55–59.
- Stanulovi, V., Hodolic, M., Mitsikostas, D., & Papadopoulos, D. (2021). Drug tolerability: How much ambiguity can be tolerated? A systematic review of the assessment of tolerability in clinical studies. British Journal of Clinical Pharmacology, 88(2), 551–565. https://doi.org/10.1111/bcp.15016